288 related articles for article (PubMed ID: 15339046)
1. Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.
Müller EJ; Caldelari R; Posthaus H
J Mol Histol; 2004 Mar; 35(3):263-75. PubMed ID: 15339046
[TBL] [Abstract][Full Text] [Related]
2. Proprotein convertase inhibition: Paralyzing the cell's master switches.
Klein-Szanto AJ; Bassi DE
Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into cadherin processing by subtilisin-like convertases.
Posthaus H; Dubois CM; Müller E
FEBS Lett; 2003 Feb; 536(1-3):203-8. PubMed ID: 12586364
[TBL] [Abstract][Full Text] [Related]
4. Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.
Khatib AM; Siegfried G; Chrétien M; Metrakos P; Seidah NG
Am J Pathol; 2002 Jun; 160(6):1921-35. PubMed ID: 12057895
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of proprotein convertases.
Basak A
J Mol Med (Berl); 2005 Nov; 83(11):844-55. PubMed ID: 16215768
[TBL] [Abstract][Full Text] [Related]
6. The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia.
Pokharel Y; Virani SS; Ballantyne CM
Curr Atheroscler Rep; 2015 May; 17(5):508. PubMed ID: 25782778
[TBL] [Abstract][Full Text] [Related]
7. Proprotein convertases: Key players in inflammation-related malignancies and metastasis.
Siegfried G; Descarpentrie J; Evrard S; Khatib AM
Cancer Lett; 2020 Mar; 473():50-61. PubMed ID: 31899298
[TBL] [Abstract][Full Text] [Related]
8. Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.
Bontemps Y; Scamuffa N; Calvo F; Khatib AM
Med Res Rev; 2007 Sep; 27(5):631-48. PubMed ID: 17019676
[TBL] [Abstract][Full Text] [Related]
9. The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitors.
Lahlil R; Calvo F; Khatib AM
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):83-91. PubMed ID: 19149690
[TBL] [Abstract][Full Text] [Related]
10. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Bassi DE; Fu J; Lopez de Cicco R; Klein-Szanto AJ
Mol Carcinog; 2005 Nov; 44(3):151-61. PubMed ID: 16167351
[TBL] [Abstract][Full Text] [Related]
11. Proprotein convertases as therapeutic targets.
Chrétien M; Seidah NG; Basak A; Mbikay M
Expert Opin Ther Targets; 2008 Oct; 12(10):1289-300. PubMed ID: 18781827
[TBL] [Abstract][Full Text] [Related]
12. Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum.
Majumdar S; Mohanta BC; Chowdhury DR; Banik R; Dinda B; Basak A
Curr Med Chem; 2010; 17(19):2049-58. PubMed ID: 20423311
[TBL] [Abstract][Full Text] [Related]
13. Proprotein convertases: lessons from knockouts.
Scamuffa N; Calvo F; Chrétien M; Seidah NG; Khatib AM
FASEB J; 2006 Oct; 20(12):1954-63. PubMed ID: 17012247
[TBL] [Abstract][Full Text] [Related]
14. The proprotein convertases are potential targets in the treatment of dyslipidemia.
Seidah NG; Prat A
J Mol Med (Berl); 2007 Jul; 85(7):685-96. PubMed ID: 17351764
[TBL] [Abstract][Full Text] [Related]
15. An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low-density lipoprotein cholesterol.
Ling H; Burns TL; Hilleman DE
Cardiovasc Ther; 2014 Apr; 32(2):82-8. PubMed ID: 24354905
[TBL] [Abstract][Full Text] [Related]
16. Enediynyl peptides and iso-coumarinyl methyl sulfones as inhibitors of proprotein convertases PCSK8/SKI-1/S1P and PCSK4/PC4: Design, synthesis and biological evaluations.
Basak A; Goswami M; Rajkumar A; Mitra T; Majumdar S; O'Reilly P; Bdour HM; Trudeau VL; Basak A
Bioorg Med Chem Lett; 2015; 25(10):2225-37. PubMed ID: 25881830
[TBL] [Abstract][Full Text] [Related]
17. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Bassi DE; Mahloogi H; Klein-Szanto AJ
Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.
Bryan RT
Philos Trans R Soc Lond B Biol Sci; 2015 Feb; 370(1661):20140042. PubMed ID: 25533099
[TBL] [Abstract][Full Text] [Related]
19. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy.
Joseph L; Robinson JG
Prog Cardiovasc Dis; 2015; 58(1):19-31. PubMed ID: 25936907
[TBL] [Abstract][Full Text] [Related]
20. Processing of pro-thrombostasin by a recombinant subtilisin-like proprotein convertase derived from the salivary glands of horn flies (Haematobia irritans).
Zhang D; Cupp MS; Cupp EW
Insect Biochem Mol Biol; 2004 Dec; 34(12):1289-95. PubMed ID: 15544942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
